Identification of bidirectional promoters in the human KIR genes

Genes and Immunity

Volumn 8, Issue 3, 2007, Pages 245-253

  Davies, G E ^a   Locke, S M ^b   Wright, P W ^a   Li, H ^a   Hanson, R J ^c   Miller, J S ^c   Anderson, S K ^a,b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2 DL4 PROTEIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3 DL1 PROTEIN; RECEPTOR PROTEIN; SPACER DNA; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ARTICLE; BINDING SITE; CELL MATURATION; CELL STRAIN HEK293; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE MAPPING; GENOME SIZE; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; START CODON; STEM CELL; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; DNA, ANTISENSE; DNA, COMPLEMENTARY; HUMANS; KILLER CELLS, NATURAL; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RECEPTORS, IMMUNOLOGIC;

MURINAE;

EID: 34247625129     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364381     Document Type: Article

References (33)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187-376.
2. Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23: 225-274.
3. Desrosiers MP, Kielczewska A, Loredo-Osti JC, Adam SG, Makrigiannis AP, Lemieux S et al. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat Genet 2005; 37: 593-599.
4. Carrington M, Norman P. The KIR Gene Cluster. National Library of Medicine (US), NCBI: Bethesda, MD, 2001.
5. Anderson SK, Ortaldo JR, McVicar DW The ever-expanding Ly49 gene family: Repertoire and signaling. Immunol Rev 2001; 181: 79-89.
6. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005; 5: 201-214.
7. + natural killer (NK) cells by the expression of clonally distributed functional surface molecules: Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 1990; 172: 1589-1598.
8. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997; 7: 739-751.
9. Held W, Kunz B. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire. Eur J Immunol 1998; 28: 2407-2416.
10. Piguet V. Receptor modulation in viral replication. HIV, HSV, HHV-8 and HPV: Same goal, different techniques to interfere with MHC-I antigen presentation. Curr Top Microbiol Immunol 2005; 285: 199-217.
11. Uhrberg M, Valiante NM, Young NT, Lanier LL, Phillips JH, Parham P. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: Clones sharing identical αβ TCR rearrangement express highly diverse killer cell Ig-like receptor patterns. J Immunol 2001; 166: 3923-3932.
12. McMahon CW, Raulet DH. Expression and function of NK receptors in CD8+ T cells. Curr Opin Immunol 2001; 13: 465-470.
13. Saleh A, Davies GE, Pascal V, Wright PW, Hodge DL, Cho EH et al. Identification of probabilistic transcriptional switches in the Ly49 gene cluster: A eukaryotic mechanism for selective gene activation. Immunity 2004; 21: 55-66.
14. Tanamachi DM, Moniot DC, Cado D, Liu SD, Hsia JK, Raulet DH. Genomic Ly49A transgenes: Basis of variegated Ly49A gene expression and identification of a critical regulatory element. J Immunol 2004; 172: 1074-1082.
15. Makrigiannis AP, Patel D, Goulet ML, Dewar K, Anderson SK. Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes. Genes Immun 2005; 6: 71-83.
16. Anderson SK, Dewar K, Goulet ML, Leveque G, Makrigiannis AP. Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype. Genes Immun 2005; 6: 481-492.
17. Stewart CA, van Bergen J, Trowsdale J. Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters. J Immunol 2003; 170: 6073-6081.
18. van Bergen J, Stewart CA, van den Elsen PJ, Trowsdale J. Structural and functional differences between the promoters of independently expressed killer cell Ig-like receptors. Eur J Immunol 2005; 35: 2191-2199.
19. Vilches C, Gardiner CM, Parham P. Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. J Immunol 2000; 165: 6416-6421.
20. Trompeter H-I, Gomez-Lozano N, Santourlidis S, Eisermann B, Wernet P, Vilches C et al. Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3. J Immunol 2005; 174: 4335-4343.
21. Xu J, Vallejo AN, Jiang Y, Weyand CM, Goronzy JJ. Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells. J Biol Chem 2005; 280: 24277-24285.
22. Stulberg MJ, Wright PW, Dang H, Hanson RJ, Miller JS, Anderson SK. Identification of distal KIR promoters and transcripts. Genes Immun advance online publication, December 7, 2006; doi:10.1038/ sj.gene.6364363.
23. Shilling HG, Young N, Guethlein LA, Cheng NW, Gardiner CM, Tyan D et al. Genetic control of human NK cell repertoire. J Immunol 2002; 169: 239-247.
24. Chan HW, Kurago ZB, Stewart CA, Wilson MJ, Martin MP, Mace BE et al. DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J Exp Med 2003; 197:245-255.
25. Radeloff B, Nagler L, Zirra M, Ziegler A, Volz A. Specific amplification of cDNA ends (SPACE): A new tool for the analysis of rare transcripts and its application for the promoter analysis of killer cell receptor genes. DNA Sequence 2005; 16: 44-52.
26. Miller JS, Brungaard K, Oostendorp RAJ, McCullar V. Murine embryonic liver differentiates human stem cells into a spectrum of NK precursors and polyclonal KIR expressing NK cells. Blood 2005; 106: 3317.
27. Gosselin P, Makrigiannis AP, Nalewaik R, Anderson SK. Characterization of the Ly491 promoter. Immunogenetics 2000; 51: 326-331.
28. McQueen KL, Wilhelm BT, Takei F, Mager DL. Functional analysis of 5′ and 3′ regions of the closely related Ly49c and j genes. Immunogenetics 2001; 52: 212-223.
29. Morris KV, Chan SW, Jacobsen SE, Looney DJ. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 2004; 305: 1289-1292.
30. Santourlidis S, Trompeter HI, Weinhold S, Eisermann B, Meyer KL, Wernet P et al. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J Immunol 2002; 169: 4253-4261.
31. Chan HW, Miller JS, Moore MB, Lutz CT. Epigenetic control of highly homologous killer immunoglobulin-like receptor gene alleles. J. Immunol 2005; 175: 5966-5974.
32. Yawata M, Yawata N, Draghi M, Little AM, Partheniou F, Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 2006; 203: 633-645.
33. Young NT. Immunobiology of natural killer lymphocytes in transplantation. Transplantation 2004; 78: 1-6.